Russell Investments Group Ltd. Has $9.24 Million Stock Holdings in AptarGroup, Inc. (NYSE:ATR)

Russell Investments Group Ltd. lessened its position in AptarGroup, Inc. (NYSE:ATR – Get Rating) by 28.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 83,753 shares of the industrial products company’s stock after selling 32,848 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.13% of AptarGroup worth $9,241,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Rockefeller Capital Management L.P. raised its stake in shares of AptarGroup by 76.3% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 328 shares of the industrial products company’s stock worth $31,000 after purchasing an additional 142 shares in the last quarter. Riverview Trust Co raised its stake in shares of AptarGroup by 53.1% during the 4th quarter. Riverview Trust Co now owns 375 shares of the industrial products company’s stock worth $41,000 after purchasing an additional 130 shares in the last quarter. CWM LLC raised its stake in shares of AptarGroup by 58.3% during the 3rd quarter. CWM LLC now owns 551 shares of the industrial products company’s stock worth $52,000 after purchasing an additional 203 shares in the last quarter. Ellevest Inc. raised its stake in shares of AptarGroup by 107.5% during the 3rd quarter. Ellevest Inc. now owns 606 shares of the industrial products company’s stock worth $58,000 after purchasing an additional 314 shares in the last quarter. Finally, Financial Advocates Investment Management bought a new stake in shares of AptarGroup during the 3rd quarter worth approximately $58,000. Institutional investors and hedge funds own 89.37% of the company’s stock.

AptarGroup Price Performance

AptarGroup stock opened at $120.79 on Friday. The company has a current ratio of 1.42, a quick ratio of 0.93 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $7.90 billion, a PE ratio of 34.81, a P/E/G ratio of 4.30 and a beta of 0.64. AptarGroup, Inc. has a 12 month low of $90.23 and a 12 month high of $122.50. The stock has a 50-day moving average price of $117.17 and a two-hundred day moving average price of $111.72.

AptarGroup (NYSE:ATR – Get Rating) last posted its earnings results on Friday, April 28th. The industrial products company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.90 by $0.05. The firm had revenue of $860.07 million during the quarter, compared to the consensus estimate of $829.92 million. AptarGroup had a return on equity of 12.53% and a net margin of 6.94%. The business’s quarterly revenue was up 1.8% on a year-over-year basis. During the same period last year, the company earned $0.96 earnings per share. Analysts expect that AptarGroup, Inc. will post 4.04 EPS for the current year.

AptarGroup Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 25th. Stockholders of record on Thursday, May 4th will be given a dividend of $0.38 per share. The ex-dividend date is Wednesday, May 3rd. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.26%. AptarGroup’s dividend payout ratio (DPR) is 43.80%.

Insider Transactions at AptarGroup

In other news, CFO Robert Kuhn sold 64,560 shares of the firm’s stock in a transaction dated Tuesday, February 21st. The stock was sold at an average price of $114.04, for a total transaction of $7,362,422.40. Following the completion of the transaction, the chief financial officer now directly owns 54,044 shares in the company, valued at $6,163,177.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other AptarGroup news, CFO Robert Kuhn sold 64,560 shares of the firm’s stock in a transaction that occurred on Tuesday, February 21st. The stock was sold at an average price of $114.04, for a total value of $7,362,422.40. Following the completion of the sale, the chief financial officer now owns 54,044 shares of the company’s stock, valued at $6,163,177.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Maritza Gomez Montiel sold 1,500 shares of the firm’s stock in a transaction that occurred on Tuesday, February 21st. The shares were sold at an average price of $114.67, for a total value of $172,005.00. Following the completion of the sale, the director now directly owns 4,024 shares of the company’s stock, valued at approximately $461,432.08. The disclosure for this sale can be found here. Insiders sold 72,060 shares of company stock worth $8,248,427 over the last ninety days. 1.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ATR. Bank of America increased their price target on AptarGroup from $132.00 to $152.00 and gave the company a “buy” rating in a research note on Thursday, April 20th. Wells Fargo & Company increased their price target on AptarGroup from $121.00 to $132.00 and gave the company an “overweight” rating in a research note on Tuesday, February 21st. Robert W. Baird increased their price target on AptarGroup from $115.00 to $125.00 in a research note on Monday, May 1st. Deutsche Bank Aktiengesellschaft increased their price target on AptarGroup from $130.00 to $134.00 in a research note on Monday, May 1st. Finally, StockNews.com initiated coverage on AptarGroup in a research report on Thursday, March 16th. They set a “buy” rating on the stock. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $131.33.

AptarGroup Profile

(Get Rating)

AptarGroup, Inc engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage.